Quoin Pharma awards CEO $331k and COO $265k in 2024 cash bonuses

Quoin Pharmaceuticals, Ltd.

Compensation Committee approved 2024 annual cash bonus of $331,238 for CEO Dr. Michael Myers.
COO Denise Carter received 2024 annual cash bonus of $264,640.
Bonuses are consistent with CEO and COO compensation programs approved at Dec 5, 2024 shareholder meeting.

item 5.02

Quoin Pharmaceuticals, Ltd. filing history →

Source: SEC EDGAR

accession 0001104659-25-056378

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.